# A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial

> **NCT04183660** · — · RECRUITING · sponsor: **Hemovent GmbH** · enrollment: 60 (estimated)

## Conditions studied

- Cardiac Failure
- Respiratory Failure
- Cardio-Respiratory Failure
- Imminent Cardiorespiratory or Respiratory Failure

## Interventions

- **DEVICE:** MOBYBOX System

## Key facts

- **NCT ID:** NCT04183660
- **Lead sponsor:** Hemovent GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-30
- **Primary completion:** 2026-04
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183660, "A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04183660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*